🔴 ProMIS Neurosciences is trading 8% down with no clear catalyst identified

ProMIS Neurosciences is trading 7.92% down at $3.17, with no clear company-specific catalyst identified for the November 4 decline.

• The company’s latest announcement said it will report third-quarter results and provide a business update on November 12; that announcement does not explain the decline.
• Biotech shares are rising, so the sector trend does not account for ProMIS Neurosciences’ decline.